Bird Migration and Avian Influenza Transmission: Mechanism, Prevention, and Control
DOI:
https://doi.org/10.54097/3fys4815Keywords:
Migratory Birds, AIV, Limitation, Future Prevention and Control SystemAbstract
Migratory birds have extensive global migration routes and play a crucial role in the intercontinental and cross-species spread of avian influenza virus (AIV). They cause the spread of infection of H3N8, H5N1, and H9N2 in humans worldwide, posing a significant threat to public health. This review explores the transmission pattern by examining the migratory routes of birds and the mechanisms by which viruses are transmitted between birds and mammals. It then delves into the review to elaborate on the infection mechanism that includes the binding of HA and sialic acid on host cells and the mutation strategies of the virus. The research also analyzes limitations of recent prevention and treatment methods, such as defects of inactive vaccines and Oseltamivir. In conclusion, the review proposes future directions, including developing broad-spectrum and T-cell inducible vaccines, exploring the pharmaceutical use value of plant extracts, aiming to provide a basis for establishing precise prevention and control strategies and treating birds and mammals efficiently to safeguard human and ecosystem health.
Downloads
References
[1] Xu, N., & Lu, X. (2022). Research on the migration and conservation of shorebirds in the Yellow and Bohai Sea wetlands. Open Journal of Natural Science, 10, 201.
[2] Hénaux, V., & Samuel, M. D. (2011). Avian influenza shedding patterns in waterfowl: Implications for surveillance, environmental transmission, and disease spread. Journal of Wildlife Diseases, 47(3), 566–578.
[3] Clark, L., & Hall, J. (2006). Avian Influenza in wild birds: Status as reservoirs, and risks to humans and agriculture. Ornithological Monographs, 60, 3–29.
[4] Lebarbenchon, C., Sreevatsan, S., Lefevre, T., Yang, M., Ramakrishnan, M. A., Brown, J. D., & Stallknecht, D. E. (2012). Reassortant influenza A viruses in wild duck populations: Effects on viral shedding and persistence in water. Proceedings of the Royal Society B: Biological Sciences, 279(1740), 3020-3026.
[5] Zhang, X. (n.d.). Analysis of Genetic Variation of Avian Influenza Virus in Migratory Birds and Study on Its Transmission Mechanism in Mammals. (Doctoral dissertation, Jilin University).
[6] Liu, F., & Ba, Y. (2025). The role of NF-κB signaling pathway in acute lung injury and research progress of traditional Chinese medicine intervention. China Pharmacy, 36(10), 1277-1282.
[7] Reperant, L. A., Grenfell, B. T., & Osterhaus, A. D. M. E. (2015). Quantifying the risk of pandemic influenza virus evolution by mutation and re-assortment. Vaccine, 33(47), 6524-6531.
[8] Matsuoka, Y., Matsumae, H., Katoh, M., et al. (2013). A comprehensive influenza A virus replication cycle map. BMC Systems Biology, 7, 97.
[9] Xu, G. L., Zhang, X. X., Gao, W. H., et al. (2016). Prevailing PA mutation K356R in avian influenza H9N2 virus increases mammalian replication and pathogenicity. Journal of Virology, 90(18), 8105–8114.
[10] Zhu, Y., Wei, Y., Sun, C., & He, H. (2021). Research progress of novel coronavirus pneumonia vaccine. Preventive Medicine, 33(2), 143-148.
[11] Liu, Z., Fu, X., Luo, C., Zhao, X., Zhang, M., Sun, Y., Chen, Y., Han, X., Ni, R., & Mao, Z. (2025). Whole genome sequence analysis of 8 H9N2 subtype avian influenza viruses from live poultry markets in Yunnan Province in 2023.Chinese Journal of Tropical Medicine, 25(3), 350-357.
[12] Zhu, W., & Shu, Y. (2015). Research progress on the etiology of novel H7N9 avian influenza virus. Life Science, 27(5), 518-524.
[13] Cramer, J. P. (2019). Principles of Immunization. In J. S. Keystone, P. E. Kozarsky, B. A. Connor, H. D. Nothdurft, M. Mendelson, & K. Leder (Eds.), Travel Medicine(4th ed., pp. 65-73). Elsevier.
[14] Huang, C. T., Oyang, Y. J., Huang, H. C., & Juan, H. F. (2014). MicroRNA-mediated networks underlie immune response regulation in papillary thyroid carcinoma. Scientific Reports, 4, 6495.
[15] Liu, Y., Zhao, D., Zhang, J., Huang, X., Han, K., Liu, Q., Yang, J., Zhang, L., & Li, Y. (2023). Development of an inactivated avian influenza virus vaccine against circulating H9N2 in chickens and ducks. Vaccines, 11(3), 596.
[16] Wang, Y., Zhang, R., Li, J., et al. (2017). Comprehensive resistome analysis reveals the prevalence of NDM and MCR-1 in Chinese poultry production.Nature Microbiology, 2, 16260.
[17] Chi, Y. (2018). Study on the quasispecies evolution and its significance of H7N9 avian influenza virus under the selective pressure of neuraminidase inhibitors. (Doctoral dissertation, Nanjing Medical University).
[18] Tabynov, K., Kuanyshbek, A., Yelchibayeva, L., Zharmambet, K., Zhumadilova, Z., Fomin, G., Petrovsky, N., Shekoni, O. C., Renukaradhya, G. J., & Tabynov, K. (2025). Evaluation of safety, immunogenicity, and efficacy of inactivated reverse-genetics-based H5N8 highly pathogenic avian influenza virus vaccine with various adjuvants via parenteral and mucosal routes in chickens. Frontiers in Immunology, 16.
[19] Fang, S. (n.d.).Study on the inhibitory effect of oseltamivir on various subtypes of influenza viruses and the screening of traditional Chinese medicine monomers for drug-resistant strains. (Doctoral dissertation, Anhui University of Chinese Medicine).
[20] Alasiri, A., Soltane, R., Hegazy, A., Khalil, A. M., Mahmoud, S. H., Khalil, A. A., Martinez-Sobrido, L., & Mostafa, A. (2023). Vaccination and antiviral treatment against avian influenza H5Nx viruses: A harbinger of virus control or evolution. Vaccines, 11(11), 1628.
[21] Eickhoff, C. S., Terry, F. E., Peng, L., Meza, K. A., Sakala, I. G., Van Aartsen, D., Moise, L., Martin, W. D., Schriewer, J., Buller, R. M., De Groot, A. S., & Hoft, D. F. (2019). Highly conserved influenza T cell epitopes induce broadly protective immunity.Vaccine, 37(36), 5371-5381.
[22] De Groot, A. S., Moise, L., Liu, R., Gutierrez, A. H., Terry, F., Koita, O. A., & Martin, W. (2014). Cross-conservation of T-cell epitopes: Now even more relevant to (H7N9) influenza vaccine design. Human Vaccines & Immunotherapeutics, 10(2), 256–262.
[23] Wan, W., Chang, J., Zhu, D., & Chen, W. (2022). Research progress on the anti-fibrosis effect of hesperidin and its derivatives. Chinese Journal of Pharmacovigilance, 19(05), 579-584.
[24] Liu, F., & Ba, Y. (2025). The role of NF-κB signaling pathway in acute lung injury and research progress of traditional Chinese medicine intervention. China Pharmacy, 36(10), 1277-1282.
[25] Song, Y., Zhang, N., Guo, M., & Wu, W. (2023). Research progress of paeoniflorin in respiratory diseases. Advances in Clinical Medicine, 13(6), 10016-10021.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
